HTB homepage • Conference reports • Articles by subject • Subscribe August 2014 Contents Editorial July/August 2014: Volume 15 Number 7/8 Conference reports 20th International AIDS Conference, 20-25 July 2014, Melbourne The loss of friends and colleagues from flight MH 17 Higher ART coverage is associated with lower HIV infection rates in a multi-country analysis Pill A, Pill B: simplified second-line treatment for low-income countries UNAIDS sets 90-90-90 target for 2020 to end AIDS by 2030 No difference in overall anaemia rate with reduced dose AZT Open label oral PrEP at four doses a week: why zero infections does not equal 100% efficacy Cure research at IAS 2014: TILDA measures the reservoir and romidepsin wakes it up HIV and transgender issues at AIDS 2014 Transgender services and clinics: interviews at AIDS 2014 with JoAnne Keatley and Beatriz Grinsztejn Publications launched at AIDS 2014 6th International Workshop on HIV Paediatrics, 18-19 July 2014, Melbourne Update on paediatric antiretrovirals Is d4T a viable option for children in low-income countries? 3TC or FTC monotherapy suboptimal as a bridging strategy for adolescents Rationalising the paediatric antiretroviral formulary in Malawi Time to first-line failure in the IeDEA cohort Influence of early ART on antibody detection in children 8th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-Poor Settings (INTEREST), 5-6 May 2014, Lusaka, Zambia Short-term safety of atazanavir/ritonavir-based second line treatment in Zambia Pregnancy outcomes in Zambia Uptake of ART is influenced by distance to the health facility in rural Zambia Genotyping using dried blood spots in rural South African setting Antiretrovirals Dolutegravir-based single-tablet regimen set for EU approval Treatment access New ARV prescribing guidelines for London (2014) Paediatric care Wrestling with the implications of the Mississippi case Guidelines WHO guidelines for key populations (July 2014): gay men, people who inject drugs, people in prisons, sex workers, transgender people EASL update guidelines for hepatitis C (April 2014) Side effects Bone mineral density linked to inflammatory markers in HIV positive people who are ART naïve Hepatitis coinfection US Senate investigate Gilead for sofosbuvir price: potential to bankrupt Federal healthcare and add $300 annually to every American insurance premium for the next five years Cure-related research Effects of long-term ART initiated during primary HIV infection on reservoir size Basic science and immunology Molecular events in HIV neutralising antibody development On the web Community reports and briefings Online journals PDFs Volume 15 Number 7/8 July/August 2014 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
